Share chart Teva Pharmaceutical Industries
About Teva Pharmaceutical Industries
Teva Pharmaceutical Industries Ltd. (ивр. טבע תעשיות פרמצבטיות בע"מ) — транснациональная фармацевтическая компания со штаб-квартирой в Петах-Тикве, Израиль. Компания специализируется на производстве препаратов-дженериков, действующих веществ, и в меньшей степени, собственных препаратов.
Компания занимает 16 место в списке крупнейших фармацевтических производителей и 704 место в рейтинге крупнейших мировых компаний Forbes Global 2000. В активе компании находятся 80 заводов, а сама корпорация осуществляет свою деятельность в 60 странах. Teva является членом американской ассоциации фармацевтических исследователей и производителей.
Main settings
Grade
Underestimation
Title | Value | Grade |
P/S | 1.53 | 8 |
P/BV | 4.41 | 4 |
P/E | 872 | 1 |
Efficiency
Title | Value | Grade |
ROA | -3.96 | 0 |
ROE | -25.44 | 0 |
ROIC | -0.29 | 0 |
Dividends
Title | Value | Grade |
Dividend yield | 0 | 0 |
DSI | 0.4286 | 4.29 |
Average dividend growth | -4.76 | 0 |
Debt
Title | Value | Grade |
Debt/EBITDA | 25.25 | 0 |
Debt/Ratio | 0.4597 | 10 |
Debt/Equity | 5.88 | 0 |
Growth impulse
Title | Value | Grade |
Yield Revenue, % | -0.6963 | 0 |
Yield Ebitda, % | -84.47 | 0 |
Yield EPS, % | -62.55 | 0 |
Dividends
Prices
Price | Min. | Max. | Change | Changes in the industry | Changes in the index | |
Yesterday | 17.71 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
Week | 17.77 $ | 0 $ | 0 $ | -0.34 % | 0 % | 0 % |
Month | 16.94 $ | 17.32 $ | 17.71 $ | 4.55 % | 0 % | 0 % |
Three month | 14.16 $ | 13.31 $ | 18.15 $ | 25.07 % | 0 % | 0 % |
Half a year | 17.06 $ | 12.82 $ | 22.01 $ | 3.81 % | 0 % | 0 % |
Year | 18.6 $ | 12.82 $ | 22.77 $ | -4.78 % | 0 % | 0 % |
3 years | 10.3 $ | 6.86 $ | 22.77 $ | 71.94 % | 0 % | 0 % |
5 years | 13.01 $ | 6.86 $ | 22.77 $ | 36.13 % | 0 % | 0 % |
10 years | 51.04 $ | 6.16 $ | 71.41 $ | -65.3 % | 0 % | 0 % |
Year to date | 21.53 $ | 12.82 $ | 22.01 $ | -17.74 % | 0 % | 0 % |
Insider trading
Main owners
Contained in ETF
ETF | Share, % | Profitability for 1 year, % | Commission, % |
Fidelity Growth Opportunities ETF | 0.24635 | -10.26 | 0.38 |
IQ 500 International ETF | 0.16121 | -6.17 | 0.25 |
0.2 | -8.21 | 0.32 |
---|
Similar companies
Company management
Head | Job title | Payment | Year of birth |
Mr. Eliyahu Sharon Kalif | Executive VP & CFO | 2.01M | 1974 (51 year) |
Mr. Amir Weiss | Senior VP & Chief Accounting Officer | N/A | 1977 (48 years) |
Mr. Mark Sabag | Executive Vice President of International Markets Commercial | 1.92M | 1971 (54 years) |
Kathleen Veit | Senior Vice President, Global Compliance & Ethics Officer | N/A | |
Mr. Richard D. Francis | President, CEO & Director | N/A | 1968 (57 years) |
Ran Meir | Head of Investor Relations | N/A | |
Ms. Vikki Conway | Acting Head of Global Human Resources | N/A | 1972 (53 years) |
Mr. Richard Gordon Daniell | Executive Vice President of European Commercial | 1967 (58 years) | |
Mr. Matthew Shields | Executive Vice President of Global Operations | 1974 (51 year) | |
Mr. David R. Mcavoy J.D. | Executive VP & Chief Legal Officer | 1963 (62 years) |
About company
Website: http://www.tevapharm.com